Chronic obstructive pulmonary disease and cardiovascular disease

Translational Research

Volumn 162, Issue 4, 2013, Pages 237-251

  Bhatt, Surya P ^b   Dransfield, Mark T ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; AZITHROMYCIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA CAROTENE; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CAROTENOID; FIBRINOGEN; FLAVONOID; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; IPRATROPIUM BROMIDE; REACTIVE OXYGEN METABOLITE; ROFLUMILAST; THEOPHYLLINE; TIOTROPIUM BROMIDE; TROPONIN T; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D;

AGE DISTRIBUTION; AORTA ANEURYSM; ARTERIAL STIFFNESS; ATHEROSCLEROSIS; BIOMASS; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; COR PULMONALE; CORONARY ARTERY DISEASE; DIASTOLIC DYSFUNCTION; DIASTOLIC HEART FAILURE; DIFFERENTIAL DIAGNOSIS; DISEASE EXACERBATION; DOPPLER ECHOCARDIOGRAPHY; DRY POWDER; DYSLIPIDEMIA; ELECTROCARDIOGRAPHY; EMPHYSEMA; ENDOTHELIAL DYSFUNCTION; FORCED EXPIRATORY VOLUME; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE BIGEMINY; HEART VENTRICLE EXTRASYSTOLE; HYPERINFLATION; INFLAMMATION; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; LONG TERM EXPOSURE; LUNG EDEMA; LUNG FUNCTION; MORTALITY; OXIDATIVE STRESS; PARTICULATE MATTER; PASSIVE SMOKING; PATHOPHYSIOLOGY; PHYSICAL INACTIVITY; PNEUMONIA; POLLUTANT; PREMATURE AGING; PRIORITY JOURNAL; PROGNOSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK FACTOR; SEDENTARY LIFESTYLE; SMOKING; SPIROMETRY; SUPRAVENTRICULAR TACHYCARDIA; SYSTEMIC CIRCULATION; SYSTOLIC HEART FAILURE; TELOMERE SHORTENING; THORAX RADIOGRAPHY; TOTAL LUNG CAPACITY; VASOCONSTRICTION;

EID: 84884546447     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2013.05.001     Document Type: Review

References (198)

1. D.D. Sin, and S.F. Man Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease Circulation 107 2003 1514 1519
2. D.M. Mannino, E.S. Ford, and S.C. Redd Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination Am J Med 114 2003 758 762
3. A. Agusti, and R. Faner Systemic inflammation and comorbidities in chronic obstructive pulmonary disease Proc Am Thorac Soc 9 2012 43 46
4. A.M. Minino, S.L. Murphy, and J. Xu Deaths: final data for 2008 Natl Vital Stat Rep 59 2011 1 126
5. M. Decramer, W. Janssens, and M. Miravitlles Chronic obstructive pulmonary disease Lancet 379 2012 1341 1351
6. D.M. Mannino, D.M. Homa, and L.J. Akinbami Chronic obstructive pulmonary disease surveillance: United States, 1971-2000 MMWR Surveill Summ 51 2002 1 16
7. Centers for Disease Control and Prevention Prevalence of coronary heart disease: United States, 2006-2010 MMWR Morb Mortal Wkly Rep 60 2011 1377 1381
8. V.L. Roger, A.S. Go, and D.M. Lloyd-Jones Heart disease and stroke statistics-2011 update: a report from the American Heart Association Circulation 123 2011 e18 e209
9. D.D. Sin, and S.F. Man Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality Proc Am Thorac Soc 2 2005 8 11
10. D.J. Hole, G.C. Watt, and G. Davey-Smith Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study BMJ 313 1996 711 715 discussion 715-6
11. N.R. Anthonisen, J.E. Connett, and P.L. Enright Hospitalizations and mortality in the Lung Health Study Am J Respir Crit Care Med 166 2002 333 339
12. S.M. Curkendall, C. DeLuise, and J.K. Jones Cardiovascular disease in patients with chronic obstructive pulmonary disease: Saskatchewan Canada cardiovascular disease in COPD patients Ann Epidemiol 16 2006 63 70
13. J.R. Feary, L.C. Rodrigues, and C.J. Smith Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care Thorax 65 2010 956 962
14. S. Sidney, M. Sorel, and C.P. Quesenberry Jr. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program Chest 128 2005 2068 2075
15. J.B. Soriano, F. Rigo, and D. Guerrero High prevalence of undiagnosed airflow limitation in patients with cardiovascular disease Chest 137 2010 333 340
16. S. Behar, A. Panosh, and H. Reicher-Reiss Prevalence and prognosis of chronic obstructive pulmonary disease among 5,839 consecutive patients with acute myocardial infarction: SPRINT study group Am J Med 93 1992 637 641
17. J.W. Zhang, Y.J. Zhou, and Q. Yang Impact of chronic obstructive pulmonary diseases on outcomes and hospital days after percutaneous coronary intervention Angiology 2012 http://dx.doi.org/10.1177/0003319712458145
18. V.V. Georgiopoulou, A.P. Kalogeropoulos, and B.M. Psaty Lung function and risk for heart failure among older adults: the Health ABC Study Am J Med 124 2011 334 341
19. G. Engstrom, O. Melander, and B. Hedblad Population-based study of lung function and incidence of heart failure hospitalisations Thorax 65 2010 633 638
20. F.H. Rutten, M.J. Cramer, and D.E. Grobbee Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease Eur Heart J 26 2005 1887 1894
21. M.M. Redfield, S.J. Jacobsen, and J.C. Burnett Jr. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic JAMA 289 2003 194 202
22. T.E. Owan, and M.M. Redfield Epidemiology of diastolic heart failure Prog Cardiovasc Dis 47 2005 320 332
23. R.S. Vasan, E.J. Benjamin, and D. Levy Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective J Am Coll Cardiol 26 1995 1565 1574
24. M. Malerba, B. Ragnoli, and M. Salameh Sub-clinical left ventricular diastolic dysfunction in early stage of chronic obstructive pulmonary disease J Biol Regul Homeost Agents 25 2011 443 451
25. R. Sabit, C.E. Bolton, and A.G. Fraser Sub-clinical left and right ventricular dysfunction in patients with COPD Respir Med 104 2010 1171 1178
26. G.C. Funk, I. Lang, and P. Schenk Left ventricular diastolic dysfunction in patients with COPD in the presence and absence of elevated pulmonary arterial pressure Chest 133 2008 1354 1359
27. M. Schena, E. Clini, and D. Errera Echo-Doppler evaluation of left ventricular impairment in chronic cor pulmonale Chest 109 1996 1446 1451
28. R.G. Barr, D.A. Bluemke, and F.S. Ahmed Percent emphysema, airflow obstruction, and impaired left ventricular filling N Engl J Med 362 2010 217 227
29. N.M. Hawkins, M.C. Petrie, and P.S. Jhund Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology Eur J Heart Fail 11 2009 130 139
30. T. Truelsen, E. Prescott, and P. Lange Lung function and risk of fatal and non-fatal stroke: the Copenhagen City Heart Study Int J Epidemiol 30 2001 145 151
31. C.L. Hart, D.J. Hole, and G.D. Smith Comparison of risk factors for stroke incidence and stroke mortality in 20 years of follow-up in men and women in the Renfrew/Paisley Study in Scotland Stroke 31 2000 1893 1896
32. D. Liao, M. Higgins, and N.R. Bryan Lower pulmonary function and cerebral subclinical abnormalities detected by MRI: the Atherosclerosis Risk in Communities study Chest 116 1999 150 156
33. J. Finkelstein, E. Cha, and S.M. Scharf Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity Int J Chron Obstruct Pulm Dis 4 2009 337 349
34. K. Schnell, C.O. Weiss, and T. Lee The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999-2008 BMC Pulm Med 12 2012 26
35. M. Soderholm, E. Zia, and B. Hedblad Lung function as a risk factor for subarachnoid hemorrhage: a prospective cohort study Stroke 43 2012 2598 2603
36. R. Pecci, J. De La Fuente Aguado, and A.B. Sanjurjo Rivo Peripheral arterial disease in patients with chronic obstructive pulmonary disease Int Angiol 31 2012 444 453
37. C.A. Meijer, V.B. Kokje, and R.B. van Tongeren An association between chronic obstructive pulmonary disease and abdominal aortic aneurysm beyond smoking: results from a case-control study Eur J Vasc Endovasc Surg 44 2012 153 157
38. R.G. Barr, F.S. Ahmed, and J.J. Carr Subclinical atherosclerosis, airflow obstruction and emphysema: the MESA Lung Study Eur Respir J 39 2012 846 854
39. H.T. Shih, C.R. Webb, and W.A. Conway Frequency and significance of cardiac arrhythmias in chronic obstructive lung disease Chest 94 1988 44 48
40. J. McCord, and S. Borzak Multifocal atrial tachycardia Chest 113 1998 203 209
41. P. Buch, J. Friberg, and H. Scharling Reduced lung function and risk of atrial fibrillation in the Copenhagen City Heart Study Eur Respir J 21 2003 1012 1016
42. T. Tukek, P. Yildiz, and V. Akkaya Factors associated with the development of atrial fibrillation in COPD patients: the role of P-wave dispersion Ann Noninvasive Electrocardiol 7 2002 222 227
43. S.P. Bhatt, S. Nanda, and J.S. Kintzer Arrhythmias as trigger for acute exacerbations of chronic obstructive pulmonary disease Respir Med 106 2012 1134 1138
44. B. Sarubbi, V. Esposito, and V. Ducceschi Effect of blood gas derangement on QTc dispersion in severe chronic obstructive pulmonary disease: evidence of an electropathy? Int J Cardiol 58 1997 287 292
45. Y. Fukuchi, M. Nishimura, and M. Ichinose COPD in Japan: the Nippon COPD Epidemiology study Respirology 9 2004 458 465
46. K.K. Ho, J.L. Pinsky, and W.B. Kannel The epidemiology of heart failure: the Framingham Study J Am Coll Cardiol 22 1993 6A 13A
47. K. Ito, and P.J. Barnes COPD as a disease of accelerated lung aging Chest 135 2009 173 180
48. T. Nyunoya, M.M. Monick, and A.L. Klingelhutz Cigarette smoke induces cellular senescence via Werner's syndrome protein down-regulation Am J Respir Crit Care Med 179 2009 279 287
49. A. Csiszar, A. Podlutsky, and M.S. Wolin Oxidative stress and accelerated vascular aging: implications for cigarette smoking Front Biosci 14 2009 3128 3144
50. B. Lundback, A. Lindberg, and M. Lindstrom Not 15 but 50% of smokers develop COPD? Report from the Obstructive Lung Disease in Northern Sweden studies Respir Med 97 2003 115 122
51. M. Ezzati, and A.D. Lopez Estimates of global mortality attributable to smoking in 2000 Lancet 362 2003 847 852
52. D. Wilson, R. Adams, and S. Appleton Difficulties identifying and targeting COPD and population-attributable risk of smoking for COPD: a population study Chest 128 2005 2035 2042
53. P. Yin, C.Q. Jiang, and K.K. Cheng Passive smoking exposure and risk of COPD among adults in China: the Guangzhou Biobank Cohort Study Lancet 370 2007 751 757
54. G. Hu, Y. Zhou, and J. Tian Risk of COPD from exposure to biomass smoke: a metaanalysis Chest 138 2010 20 31
55. E. Prescott, M. Hippe, and P. Schnohr Smoking and risk of myocardial infarction in women and men: longitudinal population study BMJ 316 1998 1043 1047
56. S. Yusuf, S. Hawken, and S. Ounpuu Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study Lancet 364 2004 937 952
57. J. He, S. Vupputuri, and K. Allen Passive smoking and the risk of coronary heart disease: a meta-analysis of epidemiologic studies N Engl J Med 340 1999 920 926
58. K. Mortimer, S.B. Gordon, and S.K. Jindal Household air pollution is a major avoidable risk factor for cardiorespiratory disease Chest 142 2012 1308 1315
59. A. Ekici, M. Ekici, and E. Kurtipek Obstructive airway diseases in women exposed to biomass smoke Environ Res 99 2005 93 98
60. E. Hnizdo, P.A. Sullivan, and K.M. Bang Association between chronic obstructive pulmonary disease and employment by industry and occupation in the US population: a study of data from the Third National Health and Nutrition Examination Survey Am J Epidemiol 156 2002 738 746
61. A. Zanobetti, M.A. Bind, and J. Schwartz Particulate air pollution and survival in a COPD cohort Environ Health 7 2008 48
62. C.A. Pope III, and D.W. Dockery Health effects of fine particulate air pollution: lines that connect J Air Waste Manage Assoc 56 2006 709 742
63. R.D. Brook, S. Rajagopalan, and C.A. Pope III Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association Circulation 121 2010 2331 2378
64. M.K. Han, D. Postma, and D.M. Mannino Gender and chronic obstructive pulmonary disease: why it matters Am J Respir Crit Care Med 176 2007 1179 1184
65. P. Kirkpatrick, and M.T. Dransfield Racial and sex differences in chronic obstructive pulmonary disease susceptibility, diagnosis, and treatment Curr Opin Pulm Med 15 2009 100 104
66. S. Ben-Zaken Cohen, P.D. Pare, and S.F. Man The growing burden of chronic obstructive pulmonary disease and lung cancer in women: examining sex differences in cigarette smoke metabolism Am J Respir Crit Care Med 176 2007 113 120
67. J.A. Baron, C. La Vecchia, and F. Levi The antiestrogenic effect of cigarette smoking in women Am J Obstet Gynecol 162 1990 502 514
68. M.D. Eisner, N. Anthonisen, and D. Coultas An official American Thoracic Society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease Am J Respir Crit Care Med 182 2010 693 718
69. I. Miedema, E.J. Feskens, and D. Heederik Dietary determinants of long-term incidence of chronic nonspecific lung diseases: the Zutphen Study Am J Epidemiol 138 1993 37 45
70. P.N. Black, and R. Scragg Relationship between serum 25-hydroxyvitamin D and pulmonary function in the Third National Health and Nutrition Examination Survey Chest 128 2005 3792 3798
71. R. Jiang, D.C. Paik, and J.L. Hankinson Cured meat consumption, lung function, and chronic obstructive pulmonary disease among United States adults Am J Respir Crit Care Med 175 2007 798 804
72. A. Mente, L. de Koning, and H.S. Shannon A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease Arch Intern Med 169 2009 659 669
73. R. Ross Atherosclerosis: an inflammatory disease N Engl J Med 340 1999 115 126
74. G.K. Hansson Inflammation, atherosclerosis, and coronary artery disease N Engl J Med 352 2005 1685 1695
75. T. Suwa, J.C. Hogg, and K.B. Quinlan Particulate air pollution induces progression of atherosclerosis J Am Coll Cardiol 39 2002 935 942
76. Q. Sun, A. Wang, and X. Jin Long-term air pollution exposure and acceleration of atherosclerosis and vascular inflammation in an animal model JAMA 294 2005 3003 3010
77. J.H. Vernooy, M. Kucukaycan, and J.A. Jacobs Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum Am J Respir Crit Care Med 166 2002 1218 1224
78. S. Sethi, C. Wrona, and K. Eschberger Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary disease Am J Respir Crit Care Med 177 2008 491 497
79. P.J. Barnes Future treatments for chronic obstructive pulmonary disease and its comorbidities Proc Am Thorac Soc 5 2008 857 864
80. P.J. Barnes The cytokine network in asthma and chronic obstructive pulmonary disease J Clin Invest 118 2008 3546 3556
81. N.L. Mills, H. Tornqvist, and M.C. Gonzalez Ischemic and thrombotic effects of dilute diesel-exhaust inhalation in men with coronary heart disease N Engl J Med 357 2007 1075 1082
82. M. Briet, C. Collin, and S. Laurent Endothelial function and chronic exposure to air pollution in normal male subjects Hypertension 50 2007 970 976
83. A.V. Diez Roux, A.H. Auchincloss, and T.G. Franklin Long-term exposure to ambient particulate matter and prevalence of subclinical atherosclerosis in the Multi-Ethnic Study of Atherosclerosis Am J Epidemiol 167 2008 667 675
84. C.A. Pope III, J.B. Muhlestein, and H.T. May Ischemic heart disease events triggered by short-term exposure to fine particulate air pollution Circulation 114 2006 2443 2448
85. F. Dominici, R.D. Peng, and M.L. Bell Fine particulate air pollution and hospital admission for cardiovascular and respiratory diseases JAMA 295 2006 1127 1134
86. J. Hung, J.Y. Lam, and L. Lacoste Cigarette smoking acutely increases platelet thrombus formation in patients with coronary artery disease taking aspirin Circulation 92 1995 2432 2436
87. I. Ikonomidis, J. Lekakis, and G. Vamvakou Cigarette smoking is associated with increased circulating proinflammatory and procoagulant markers in patients with chronic coronary artery disease: effects of aspirin treatment Am Heart J 149 2005 832 839
88. M. Howe, A. Leidal, and D. Montgomery Role of cigarette smoking and gender in acute coronary syndrome events Am J Cardiol 108 2011 1382 1386
89. Centers for Disease Control and Prevention (US), National Center for Chronic Disease Prevention and Health Promotion (US), Office on Smoking and Health (US). How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease. A Report of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention (US); 2010. Available from: http://www.ncbi.nlm.nih.gov/books/NBK53017/, accessed June 06, 2013.
90. L. Smeeth, S.L. Thomas, and A.J. Hall Risk of myocardial infarction and stroke after acute infection or vaccination N Engl J Med 351 2004 2611 2618
91. S. Ebrahim, O. Papacosta, and P. Whincup Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study Stroke 30 1999 841 850
92. E.B. Schroeder, V.L. Welch, and G.W. Evans Impaired lung function and subclinical atherosclerosis: the ARIC study Atherosclerosis 180 2005 367 373
93. M. Zureik, F. Kauffmann, and P.J. Touboul Association between peak expiratory flow and the development of carotid atherosclerotic plaques Arch Intern Med 161 2001 1669 1676
94. H. Iwamoto, A. Yokoyama, and Y. Kitahara Airflow limitation in smokers is associated with subclinical atherosclerosis Am J Respir Crit Care Med 179 2009 35 40
95. S. Frantz, U. Nihlen, and M. Dencker Atherosclerotic plaques in the internal carotid artery and associations with lung function assessed by different methods Clin Physiol Funct Imaging 32 2012 120 125
96. Y.R. van Gestel, W.J. Flu, and J.P. van Kuijk Association of COPD with carotid wall intima-media thickness in vascular surgery patients Respir Med 104 2010 712 716
97. L. Lahousse, Q. van den Bouwhuijsen, and D.W. Loth Chronic obstructive pulmonary disease and lipid core carotid artery plaques in the elderly: the Rotterdam Study Am J Respir Crit Care Med 187 2012 58 64
98. D.A. McAllister, J.D. Maclay, and N.L. Mills Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 176 2007 1208 1214
99. N.L. Mills, J.J. Miller, and A. Anand Increased arterial stiffness in patients with chronic obstructive pulmonary disease: a mechanism for increased cardiovascular risk Thorax 63 2008 306 311
100. R. Sabit, C.E. Bolton, and P.H. Edwards Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease Am J Respir Crit Care Med 175 2007 1259 1265
101. C. Iribarren, S. Sidney, and B. Sternfeld Calcification of the aortic arch: risk factors and association with coronary heart disease, stroke, and peripheral vascular disease JAMA 283 2000 2810 2815
102. P. Greenland, L. LaBree, and S.P. Azen Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals JAMA 291 2004 210 215
103. M.T. Dransfield, F. Huang, and H. Nath CT emphysema predicts thoracic aortic calcification in smokers with and without COPD COPD 7 2010 404 410
104. D.A. McAllister, W. MacNee, and D. Duprez Pulmonary function is associated with distal aortic calcium, not proximal aortic distensibility: MESA Lung study COPD 8 2011 71 78
105. C.E. Bolton, C.M. McEniery, and V. Raj Aortic calcification, arterial stiffness and bone mineral density in patients with COPD Artery Res 5 2011 30 36
106. F. Garcia-Rio, M. Miravitlles, and J.B. Soriano Systemic inflammation in chronic obstructive pulmonary disease: a population-based study Respir Res 11 2010 63
107. T.M. Eagan, T. Ueland, and P.D. Wagner Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study Eur Respir J 35 2010 540 548
108. V.M. Pinto-Plata, H. Mullerova, and J.F. Toso C-reactive protein in patients with COPD, control smokers and non-smokers Thorax 61 2006 23 28
109. J.M. Coulson, J.H. Rudd, and J.M. Duckers Excessive aortic inflammation in chronic obstructive pulmonary disease: an 18F-FDG PET pilot study J Nucl Med 51 2010 1357 1360
110. H.Y. Park, S.Y. Lim, and J.H. Hwang Lung function, coronary artery calcification, and metabolic syndrome in 4905 Korean males Respir Med 104 2010 1326 1335
111. S.J. Kim, D.W. Yoon, and E.J. Lee Carotid atherosclerosis in patients with untreated chronic obstructive pulmonary disease Int J Tuberc Lung Dis 15 2011 1265 1270
112. P. Eickhoff, A. Valipour, and D. Kiss Determinants of systemic vascular function in patients with stable chronic obstructive pulmonary disease Am J Respir Crit Care Med 178 2008 1211 1218
113. J.H. Janner, D.A. McAllister, and N.S. Godtfredsen Is chronic obstructive pulmonary disease associated with increased arterial stiffness? Respir Med 106 2012 397 405
114. J.D. Maclay, D.A. McAllister, and R. Rabinovich Systemic elastin degradation in chronic obstructive pulmonary disease Thorax 67 2012 606 612
115. I. Rahman, and W. MacNee Oxidative stress and regulation of glutathione in lung inflammation Eur Respir J 16 2000 534 554
116. I. Rahman, D. Morrison, and K. Donaldson Systemic oxidative stress in asthma, COPD, and smokers Am J Respir Crit Care Med 154 1996 1055 1060
117. C.A. Papaharalambus, and K.K. Griendling Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury Trends Cardiovasc Med 17 2007 48 54
118. W. Macnee, J. Maclay, and D. McAllister Cardiovascular injury and repair in chronic obstructive pulmonary disease Proc Am Thorac Soc 5 2008 824 833
119. J.L. Todd, D.B. Goldstein, and D. Ge The state of genome-wide association studies in pulmonary disease: a new perspective Am J Respir Crit Care Med 184 2011 873 880
120. A. Churg, S. Zhou, and J.L. Wright Series "matrix metalloproteinases in lung health and disease": matrix metalloproteinases in COPD Eur Respir J 39 2012 197 209
121. S. Abilleira, S. Bevan, and H.S. Markus The role of genetic variants of matrix metalloproteinases in coronary and carotid atherosclerosis J Med Genet 43 2006 897 901
122. N. Singh, N. Sinha, and S. Kumar Glutathione S-transferase gene polymorphism as a susceptibility factor for acute myocardial infarction and smoking in the North Indian population Cardiology 118 2011 16 21
123. J. Hallberg, A. Dominicus, and U.K. Eriksson Interaction between smoking and genetic factors in the development of chronic bronchitis Am J Respir Crit Care Med 177 2008 486 490
124. Z. Nong, J.M. Stassen, and L. Moons Inhibition of tissue angiotensin-converting enzyme with quinapril reduces hypoxic pulmonary hypertension and pulmonary vascular remodeling Circulation 94 1996 1941 1947
125. M. Guba, M. Steinbauer, and M. Buchner Differential effects of short-term ACE- and AT1-receptor inhibition on postischemic injury and leukocyte adherence in vivo and in vitro Shock 13 2000 190 196
126. K.T. Weber Fibrosis, a common pathway to organ failure: angiotensin II and tissue repair Semin Nephrol 17 1997 467 491
127. H. Drexler, and B. Hornig Endothelial dysfunction in human disease J Mol Cell Cardiol 31 1999 51 60
128. M.A. Lee, M. Bohm, and M. Paul Tissue renin-angiotensin systems: their role in cardiovascular disease Circulation 87 1993 IV7 13
129. D. Donaire-Gonzalez, E. Gimeno-Santos, and E. Balcells Physical activity in COPD patients: patterns and bouts Eur Respir J 2012 http://dx.doi.org/10. 1183/09031936.00101512
130. W.B. Kannel, and P.A. Wolf Peripheral and cerebral atherothrombosis and cardiovascular events in different vascular territories: insights from the Framingham study Curr Atheroscler Rep 8 2006 317 323
131. W.B. Kannel Habitual level of physical activity and risk of coronary heart disease: the Framingham study Can Med Assoc J 96 1967 811 812
132. B. Waschki, A. Kirsten, and O. Holz Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study Chest 140 2011 331 342
133. J. He, L.G. Ogden, and L.A. Bazzano Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study Arch Intern Med 161 2001 996 1002
134. P. Bhattacharyya, D. Acharjee, and S.N. Ray Left ventricular diastolic dysfunction in COPD may manifest myocardial ischemia COPD 9 2012 305 309
135. H. Watz, B. Waschki, and T. Meyer Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinflation Chest 138 2010 32 38
136. C. Vassaux, L. Torre-Bouscoulet, and S. Zeineldine Effects of hyperinflation on the oxygen pulse as a marker of cardiac performance in COPD Eur Respir J 32 2008 1275 1282
137. P. Tzani, M. Aiello, and D. Elia Dynamic hyperinflation is associated with a poor cardiovascular response to exercise in COPD patients Respir Res 12 2011 150
138. J. Butler The heart is not always in good hands Chest 97 1990 453 460
139. K. Jorgensen, M.F. Muller, and J. Nel Reduced intrathoracic blood volume and left and right ventricular dimensions in patients with severe emphysema: an MRI study Chest 131 2007 1050 1057
140. G. Mancia, R. Dell'Oro, and F. Quarti-Trevano Angiotensin-sympathetic system interactions in cardiovascular and metabolic disease J Hypertens 24 2006 S51 S56
141. I. Belenkie, E.R. Smith, and J.V. Tyberg Ventricular interaction: from bench to bedside Ann Med 33 2001 236 241
142. M. Kasner, D. Westermann, and P. Steendijk Left ventricular dysfunction induced by nonsevere idiopathic pulmonary arterial hypertension: a pressure-volume relationship study Am J Respir Crit Care Med 186 2012 181 189
143. E.K. Theofilogiannakos, A. Anogeianaki, and P. Tsekoura Arrhythmogenesis in patients with stable chronic obstructive pulmonary disease J Cardiovasc Med (Hagerstown) 9 2008 89 93
144. S.K. Chhabra, and S. De Cardiovascular autonomic neuropathy in chronic obstructive pulmonary disease Respir Med 99 2005 126 133
145. A.G. Stewart, J.C. Waterhouse, and P. Howard The QTc interval, autonomic neuropathy and mortality in hypoxaemic COPD Respir Med 89 1995 79 84
146. T.H. Le Jemtel, M. Padeletti, and S. Jelic Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure J Am Coll Cardiol 49 2007 171 180
147. D.A. Lichtenstein, and G.A. Meziere Relevance of lung ultrasound in the diagnosis of acute respiratory failure: the BLUE protocol Chest 134 2008 117 125
148. C.C. Naum, F.C. Sciurba, and R.M. Rogers Pulmonary function abnormalities in chronic severe cardiomyopathy preceding cardiac transplantation Am Rev Respir Dis 145 1992 1334 1338
149. R.W. Light, and R.B. George Serial pulmonary function in patients with acute heart failure Arch Intern Med 143 1983 429 433
150. G. Guder, F.H. Rutten, and S. Brenner The impact of heart failure on the classification of COPD severity J Card Fail 18 2012 637 644
151. A.E. Camilli, D.R. Robbins, and M.D. Lebowitz Death certificate reporting of confirmed airways obstructive disease Am J Epidemiol 133 1991 795 800
152. G.C. Donaldson, J.R. Hurst, and C.J. Smith Increased risk of myocardial infarction and stroke following exacerbation of COPD Chest 137 2010 1091 1097
153. C.L. Chang, S.C. Robinson, and G.D. Mills Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD Thorax 66 2011 764 768
154. E. Odigie-Okon, B. Jordan, and S. Dijeh Cardiac injury in patients with COPD presenting with dyspnea: a pilot study Int J Chron Obstruct Pulm Dis 5 2010 395 399
155. L.C. Boudestein, F.H. Rutten, and M.J. Cramer The impact of concurrent heart failure on prognosis in patients with chronic obstructive pulmonary disease Eur J Heart Fail 11 2009 1182 1188
156. B.J. Kwon, D.B. Kim, and S.W. Jang Prognosis of heart failure patients with reduced and preserved ejection fraction and coexistent chronic obstructive pulmonary disease Eur J Heart Fail 12 2010 1339 1344
157. A. Macchia, J.J. Rodriguez Moncalvo, and M. Kleinert Unrecognised ventricular dysfunction in COPD Eur Respir J 39 2012 51 58
158. G.H. Abusaid, A. Barbagelata, and E. Tuero Diastolic dysfunction and COPD exacerbation Postgrad Med J 121 2009 76 81
159. F. Abroug, L. Ouanes-Besbes, and N. Nciri Association of left-heart dysfunction with severe exacerbation of chronic obstructive pulmonary disease: diagnostic performance of cardiac biomarkers Am J Respir Crit Care Med 174 2006 990 996
160. A.C. Salisbury, K.J. Reid, and J.A. Spertus Impact of chronic obstructive pulmonary disease on post-myocardial infarction outcomes Am J Cardiol 99 2007 636 641
161. F. Bursi, R. Vassallo, and S.A. Weston Chronic obstructive pulmonary disease after myocardial infarction in the community Am Heart J 160 2010 95 101
162. G. Campo, P. Guastaroba, and A. Marzocchi Impact of chronic obstructive pulmonary disease on long-term outcome after ST-segment elevation myocardial infarction receiving primary percutaneous coronary intervention Chest 2013 http://dx.doi.org/10.1378/chest.12-2313
163. K. Wakabayashi, M.A. Gonzalez, and C. Delhaye Impact of chronic obstructive pulmonary disease on acute-phase outcome of myocardial infarction Am J Cardiol 106 2010 305 309
164. H.A. Hadi, M. Zubaid, and W. Al Mahmeed Prevalence and prognosis of chronic obstructive pulmonary disease among 8167 Middle Eastern patients with acute coronary syndrome Clin Cardiol 33 2010 228 235
165. M. Wilchesky, P. Ernst, and J.M. Brophy Bronchodilator use and the risk of arrhythmia in COPD. Part 1: Saskatchewan cohort study Chest 142 2012 298 304
166. M. Wilchesky, P. Ernst, and J.M. Brophy Bronchodilator use and the risk of arrhythmia in COPD. Part 2: reassessment in the larger Quebec cohort Chest 142 2012 305 311
167. C. Macie, K. Wooldrage, and J. Manfreda Cardiovascular morbidity and the use of inhaled bronchodilators Int J Chron Obstruct Pulm Dis 3 2008 163 169
168. S.S. Coughlin, C. Metayer, and E.P. McCarthy Respiratory illness, beta-agonists, and risk of idiopathic dilated cardiomyopathy: the Washington, DC, Dilated Cardiomyopathy Study Am J Epidemiol 142 1995 395 403
169. D.H. Au, J.R. Curtis, and N.R. Every Association between inhaled beta-agonists and the risk of unstable angina and myocardial infarction Chest 121 2002 846 851
170. S.R. Salpeter, T.M. Ormiston, and E.E. Salpeter Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis Chest 125 2004 2309 2321
171. D.D. Sin, and J.V. Tu Lack of association between ipratropium bromide and mortality in elderly patients with chronic obstructive airway disease Thorax 55 2000 194 197
172. S. Singh, Y.K. Loke, and C.D. Furberg Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis JAMA 300 2008 1439 1450
173. D.P. Tashkin, B. Celli, and S. Senn A 4-year trial of tiotropium in chronic obstructive pulmonary disease N Engl J Med 359 2008 1543 1554
174. S. Singh, Y.K. Loke, and P. Enright Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications Thorax 68 2013 114 116
175. S. Singh, Y.K. Loke, and P.L. Enright Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials BMJ 342 2011 d3215
176. K.M. Verhamme, A. Afonso, and S. Romio Use of tiotropium Respimat SMI vs. tiotropium Handihaler and mortality in patients with COPD Eur Respir J 2013 http://dx.doi.org/10.1183/09031936.00005813
177. J.A. van Noord, P.J. Cornelissen, and J.L. Aumann The efficacy of tiotropium administered via Respimat soft mist inhaler or HandiHaler in COPD patients Respir Med 103 2009 22 29
178. D.H. Au, E.M. Udris, and V.S. Fan Risk of mortality and heart failure exacerbations associated with inhaled beta-adrenoceptor agonists among patients with known left ventricular systolic dysfunction Chest 123 2003 1964 1969
179. C. Huerta, S.F. Lanes, and L.A. Garcia Rodriguez Respiratory medications and the risk of cardiac arrhythmias Epidemiology 16 2005 360 366
180. W.B. White, G.E. Cooke, and P.R. Kowey Cardiovascular safety in patients receiving roflumilast for the treatment of chronic obstructive pulmonary disease Chest 2013 http://dx.doi.org/10.1378/chest.12-2332
181. W.A. Ray, K.T. Murray, and K. Hall Azithromycin and the risk of cardiovascular death N Engl J Med 366 2012 1881 1890
182. C.M. O'Connor, M.W. Dunne, and M.A. Pfeffer Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial JAMA 290 2003 1459 1466
183. R.K. Albert, J. Connett, and P.G. Woodruff Azithromycin and the risk of cardiovascular death N Engl J Med 367 2012 773 774 author reply 775
184. J.T. Grayston, R.A. Kronmal, and L.A. Jackson Azithromycin for the secondary prevention of coronary events N Engl J Med 352 2005 1637 1645
185. M. Egred, S. Shaw, and B. Mohammad Under-use of beta-blockers in patients with ischaemic heart disease and concomitant chronic obstructive pulmonary disease Q J Med 98 2005 493 497
186. G.B. Mancini, M. Etminan, and B. Zhang Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease J Am Coll Cardiol 47 2006 2554 2560
187. E.M. Mortensen, L.A. Copeland, and M.J. Pugh Impact of statins and ACE inhibitors on mortality after COPD exacerbations Respir Res 10 2009 45
188. C.M. Lawes, S. Thornley, and R. Young Statin use in COPD patients is associated with a reduction in mortality: a national cohort study Prim Care Respir J 21 2012 35 40
189. V. Soyseth, P.H. Brekke, and P. Smith Statin use is associated with reduced mortality in COPD Eur Respir J 29 2007 279 283
190. M.T. Dransfield, S.M. Rowe, and J.E. Johnson Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD Thorax 63 2008 301 305
191. M.S. Stefan, M.B. Rothberg, and A. Priya Association between beta-blocker
192. M. Etminan, S. Jafari, and B. Carleton Beta-blocker use and COPD mortality: a systematic review and meta-analysis BMC Pulm Med 12 2012 48
193. S. Suissa Co-morbidity in COPD: the effects of cardiovascular drug therapies Respiration 80 2010 3 7
194. M.P. Ekstrom, A.B. Hermansson, and K.E. Strom Effects of cardiovascular drugs on mortality in severe chronic obstructive pulmonary disease Am J Respir Crit Care Med 187 2013 715 720
195. J.R. Hurst, W.R. Perera, and T.M. Wilkinson Systemic and upper and lower airway inflammation: an exacerbation of chronic obstructive pulmonary disease Am J Respir Crit Care Med 173 2006 71 78
196. I. Stanojkovic, J. Kotur-Stevuljevic, and B. Milenkovic Pulmonary function, oxidative stress and inflammatory markers in severe COPD exacerbation Respir Med 105 2011 S31 S37
197. D.E. O'Donnell, and P. Laveneziana The clinical importance of dynamic lung hyperinflation in COPD COPD 3 2006 219 232
198. A.D. Hoiseth, A. Neukamm, and B.D. Karlsson Elevated high-sensitivity cardiac troponin T is associated with increased mortality after acute exacerbation of chronic obstructive pulmonary disease Thorax 66 2011 775 781